{{Rsnum
|rsid=6870564
|Chromosome=5
|position=17002976
|Orientation=plus
|GMAF=0.2089
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 29.2 | 70.8
| HCB | 0.0 | 26.7 | 73.3
| JPT | 0.0 | 31.8 | 68.2
| YRI | 18.0 | 50.8 | 31.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 26.7 | 73.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=A
  |Pval=4E-6
  |OR=3.84
  |ORtxt=[2.21-5.47] mg/dL increase
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}